The potent roles of salt-inducible kinases (SIKs) in metabolic homeostasis and tumorigenesis
Z Sun, Q Jiang, J Li, J Guo - Signal transduction and targeted therapy, 2020 - nature.com
Salt-inducible kinases (SIKs) belong to AMP-activated protein kinase (AMPK) family, and
functions mainly involve in regulating energy response-related physiological processes …
functions mainly involve in regulating energy response-related physiological processes …
Salt-inducible kinases: physiology, regulation by cAMP, and therapeutic potential
MN Wein, M Foretz, DE Fisher, RJ Xavier… - Trends in Endocrinology …, 2018 - cell.com
Salt-inducible kinases (SIKs) represent a subfamily of AMP-activated protein kinase (AMPK)
family kinases. Initially named because SIK1 (the founding member of this kinase family) …
family kinases. Initially named because SIK1 (the founding member of this kinase family) …
Off-target toxicity is a common mechanism of action of cancer drugs undergoing clinical trials
A Lin, CJ Giuliano, A Palladino, KM John… - Science translational …, 2019 - science.org
Ninety-seven percent of drug-indication pairs that are tested in clinical trials in oncology
never advance to receive US Food and Drug Administration approval. While lack of efficacy …
never advance to receive US Food and Drug Administration approval. While lack of efficacy …
Single-cell transcriptional changes associated with drug tolerance and response to combination therapies in cancer
Tyrosine kinase inhibitors were found to be clinically effective for treatment of patients with
certain subsets of cancers carrying somatic mutations in receptor tyrosine kinases. However …
certain subsets of cancers carrying somatic mutations in receptor tyrosine kinases. However …
POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer
Small cell lung cancer (SCLC) is widely considered to be a tumor of pulmonary
neuroendocrine cells; however, a variant form of this disease has been described that lacks …
neuroendocrine cells; however, a variant form of this disease has been described that lacks …
MEF2C promotes M1 macrophage polarization and Th1 responses
X Zhao, Q Di, H Liu, J Quan, J Ling, Z Zhao… - Cellular & Molecular …, 2022 - nature.com
The polarization of macrophages to the M1 or M2 phenotype has a pivotal role in
inflammation and host defense; however, the underlying molecular mechanism remains …
inflammation and host defense; however, the underlying molecular mechanism remains …
LAG-3 sustains TOX expression and regulates the CD94/NKG2-Qa-1b axis to govern exhausted CD8 T cell NK receptor expression and cytotoxicity
Summary Exhausted CD8 T (T ex) cells in chronic viral infection and cancer have sustained
co-expression of inhibitory receptors (IRs). T ex cells can be reinvigorated by blocking IRs …
co-expression of inhibitory receptors (IRs). T ex cells can be reinvigorated by blocking IRs …
[HTML][HTML] TP63-mediated enhancer reprogramming drives the squamous subtype of pancreatic ductal adenocarcinoma
The aberrant expression of squamous lineage markers in pancreatic ductal
adenocarcinoma (PDA) has been correlated with poor clinical outcomes. However, the …
adenocarcinoma (PDA) has been correlated with poor clinical outcomes. However, the …
The interferon-stimulated gene RIPK1 regulates cancer cell intrinsic and extrinsic resistance to immune checkpoint blockade
L Cucolo, Q Chen, J Qiu, Y Yu, M Klapholz… - Immunity, 2022 - cell.com
Summary Interferon-gamma (IFN-γ) has pleiotropic effects on cancer immune checkpoint
blockade (ICB), including roles in ICB resistance. We analyzed gene expression in ICB …
blockade (ICB), including roles in ICB resistance. We analyzed gene expression in ICB …
Histone hyperacetylation disrupts core gene regulatory architecture in rhabdomyosarcoma
Core regulatory transcription factors (CR TFs) orchestrate the placement of super-enhancers
(SEs) to activate transcription of cell-identity specifying gene networks, and are critical in …
(SEs) to activate transcription of cell-identity specifying gene networks, and are critical in …